Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia
Abroad (travel likely)RecruitingPHASE1
Conditions
Xerostomia · Graft-versus-host-disease · Sjogren's Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Wisconsin, Madison, Wisconsin, United States
Study leads
Sara McCoy, MD, PhD
Principal Investigator
University of Wisconsin, Madison
Jacques Galipeau, MD
Study Director
University of Wisconsin, Madison